Antibody Invented At Charlotte Shows Promise For Pancreatic Cancer Treatment
An antibody that was invented at UNC Charlotte could be used to curb pancreatic cancer relapse and metastasis, a new UNC Charlotte study has found. Pancreatic cancer is particularly cruel — and deadly. Yet, there is hope for improved treatment options. UNC Charlotte researchers are among those leading the search for solutions, including research by Mukulika Bose ’22 Ph.D. and collaborators, including Bose’s mentor Pinku Mukherjee, published in the journal Translational Research.